The expedited approval of mpox vaccines is critical to addressing this public health emergency. Building on the practice in approving COVID-19 vaccines, this analysis investigates the regulatory ...

Background Racial and ethnic disparities in infectious disease burden have been reported in the USA and globally, most recently during the COVID-19 pandemic. It remains unclear whether such ...

Introduction Burden of non-communicable diseases (NCDs) continues to rise in low- and middle-income countries like Kenya. People with HIV (PWH) may be at greater risk for obesity and NCDs. National ...

War has devastating consequences on healthcare, with attacks becoming normalised and health weaponised. The scholarship emphasises the longterm human toll, the need for accountability, humanitarian ...

Antimicrobial resistance (AMR) refers to the ability of microbes—bacteria, viruses, fungi and parasites—to survive exposure to drugs that previously cleared them. Mostly, assessments of AMR in ...

Non-communicable diseases (NCDs) include cancers, cardiovascular diseases, diabetes, chronic respiratory disease and mental health. This group of conditions is the leading global cause of morbidity ...

Noma (cancrum oris or gangrenous stomatitis) is a severe gangrenous disease of the mouth and face. It is a non-contagious, opportunistic infection mostly affecting children aged 2–6 years and is ...

An interview with the winner of the 2020 BMJ Global Health Grant as well as information on previous winners.

Paul Bukuluki, Simon Ndira, Juliet Aweko, Angelica Kiwummulo, Michael Ediau, Justine Namakula, Elizabeth Ekirapa-Kiracho, Peter Waiswa, John J O Mogaka, Grace Bantebya ...

Introduction The WHO Foundation (WHOF) was established in 2020 with the stated aim of broadening the donor pool to the WHO. Academics and civil society actors raised concerns regarding the potential ...

Introduction The United Nations Sustainable Development Goal (UN-SDG) 3.4 aims to reduce premature mortality from non-communicable diseases, including breast cancer, by one-third by 2030 relative to ...

The recently published 2024 WHO Guidance for human genome data collection, access, use and sharing1 introduces a granularity maximisation principle, requiring informed consent to be ‘as granular as ...